دورية أكاديمية
أعرض في EDS

Persistent Symptoms Post-COVID-19: An Observational Study at King Abdulaziz Medical City, Jeddah, Saudi Arabia.

التفاصيل البيبلوغرافية
العنوان: Persistent Symptoms Post-COVID-19: An Observational Study at King Abdulaziz Medical City, Jeddah, Saudi Arabia.
المؤلفون: Jabali MA; Family Medicine, Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, SAU., Alsabban AS; Family Medicine, Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, SAU., Bahakeem LM; Family Medicine, Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, SAU., Zwawy MA; Family Medicine, Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, SAU., Bagasi AT; Family Medicine, Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, SAU., Bagasi HT; Medicine, Hera General Hospital, Makkah, SAU., Aldosary TA; Medical Sciences - Oral Biology, Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, SAU.
المصدر: Cureus [Cureus] 2022 Apr 21; Vol. 14 (4), pp. e24343. Date of Electronic Publication: 2022 Apr 21 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Background As the prevalence of COVID-19 recovery cases increased, patients started to notice new symptoms after being cured of the acute infection. We aimed to study the type of persistent symptoms post-COVID-19 infection, their prevalence, and factors that play a role in developing the post-COVID-19 symptoms among COVID-19 patients at King Abdulaziz Medical City, Jeddah, Saudi Arabia. Methods A cross-sectional study was conducted at King Abdulaziz Medical City, Jeddah, Saudi Arabia, from the period of September 2021 to December 2021. Participants were contacted via a phone interview. Statistical analysis was performed using IBM SPSS Statistics, and p-values of ≤0.05 were considered significant. Results A total of 327 participants completed the study, of which 169 (51.7%) were male. Nearly half of the patients, 161 (49.09%), had persistent symptoms. The most common symptoms were loss of smell, loss of taste, cough, and fatigue (22.6%, 19.2%, 11.6%, and 9.1% respectively). They were followed by an equal percentage of shortness of breath, headache, and hair loss (7.3%). Gender was found to be significant in loss of smell, loss of taste, and hair loss, with p-values of 0.016, 0.018, and <0.001, respectively. Conclusion A large proportion of patients with COVID-19 developed persistent symptoms. The most common symptoms were loss of smell and taste, cough, and fatigue. Some factors played a role in acquiring post-COVID-19 symptoms, including gender and place of treatment. Gender was significantly associated with hair loss. Follow-up after recovery is required to maintain individual well-being.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Jabali et al.)
References: J Clin Med. 2022 Jan 14;11(2):. (PMID: 35054108)
J Med Virol. 2021 Feb;93(2):1013-1022. (PMID: 32729939)
J Med Virol. 2021 Oct;93(10):5942-5946. (PMID: 34171139)
J Multidiscip Healthc. 2020 Oct 06;13:1089-1097. (PMID: 33116555)
JAMA. 2020 Aug 11;324(6):603-605. (PMID: 32644129)
J Infect. 2020 Dec;81(6):e4-e6. (PMID: 32853602)
EClinicalMedicine. 2021 Aug;38:101019. (PMID: 34308300)
Infection. 2022 Dec;50(6):1431-1439. (PMID: 35294728)
JAMA. 2020 May 26;323(20):2089-2090. (PMID: 32320008)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
J Infect. 2021 Mar;82(3):378-383. (PMID: 33450302)
Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16. (PMID: 34763058)
Clin Microbiol Infect. 2021 Feb;27(2):258-263. (PMID: 33031948)
Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867)
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. (PMID: 34951953)
Cureus. 2021 Sep 7;13(9):e17787. (PMID: 34659998)
J Infect Public Health. 2020 Jul;13(7):920-925. (PMID: 32534945)
EClinicalMedicine. 2021 May 24;36:100899. (PMID: 34036253)
Clin Microbiol Infect. 2021 Jan;27(1):89-95. (PMID: 32979574)
Front Med (Lausanne). 2021 May 04;8:653516. (PMID: 34017846)
Int J Clin Pract. 2021 Mar;75(3):e13746. (PMID: 32991035)
JAMA Netw Open. 2021 Feb 1;4(2):e210830. (PMID: 33606031)
Pulm Med. 2020 Sep 08;2020:7590207. (PMID: 32963831)
PLoS One. 2021 Apr 8;16(4):e0249644. (PMID: 33831043)
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. (PMID: 32730238)
فهرسة مساهمة: Keywords: covid-19; persistent covid-19; persistent symptoms; post covid-19; sars-cov
تواريخ الأحداث: Date Created: 20220524 Latest Revision: 20240828
رمز التحديث: 20240828
مُعرف محوري في PubMed: PMC9123896
DOI: 10.7759/cureus.24343
PMID: 35607525
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.24343